$ACR
ACRES Commercial Realty Corp.

2019 Q2 Form 10-Q Financial Statement

#000156459020038891 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2019 Q2
Revenue $37.14M
YoY Change 172.01%
Cost Of Revenue $23.83M
YoY Change 25.62%
Gross Profit $13.34M
YoY Change 13.34%
Gross Profit Margin 35.92%
Selling, General & Admin $2.620M
YoY Change -11.19%
% of Gross Profit 19.64%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $900.0K
YoY Change 800.0%
% of Gross Profit 6.75%
Operating Expenses $3.090M
YoY Change -48.82%
Operating Profit $10.25M
YoY Change 78.79%
Interest Expense $21.58M
YoY Change 33.55%
% of Operating Profit 210.55%
Other Income/Expense, Net -$1.250M
YoY Change -179.42%
Pretax Income $9.000M
YoY Change -2.07%
Income Tax $0.00
% Of Pretax Income 0.0%
Net Earnings $8.891M
YoY Change 1.74%
Net Earnings / Revenue 23.94%
Basic Earnings Per Share $0.60
Diluted Earnings Per Share $0.60
COMMON SHARES
Basic Shares Outstanding 31.44M
Diluted Shares Outstanding 31.66M

Balance Sheet

Concept 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $47.20M
YoY Change -41.15%
Cash & Equivalents $47.15M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $56.40M
YoY Change -35.47%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $480.4M
YoY Change 50.03%
Other Assets $30.50M
YoY Change -1.61%
Total Long-Term Assets $2.463B
YoY Change 36.49%
TOTAL ASSETS
Total Short-Term Assets $56.40M
Total Long-Term Assets $2.463B
Total Assets $2.520B
YoY Change 33.17%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.300M
YoY Change 60.61%
Accrued Expenses $5.200M
YoY Change 10.64%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.30M
YoY Change 43.97%
LONG-TERM LIABILITIES
Long-Term Debt $1.935B
YoY Change 46.66%
Other Long-Term Liabilities $6.200M
YoY Change 148.0%
Total Long-Term Liabilities $1.942B
YoY Change 46.85%
TOTAL LIABILITIES
Total Short-Term Liabilities $20.30M
Total Long-Term Liabilities $1.942B
Total Liabilities $1.962B
YoY Change 46.81%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.084B
YoY Change 0.2%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $558.0M
YoY Change
Total Liabilities & Shareholders Equity $2.520B
YoY Change 33.17%

Cashflow Statement

Concept 2019 Q2
OPERATING ACTIVITIES
Net Income $8.891M
YoY Change 1.74%
Depreciation, Depletion And Amortization $900.0K
YoY Change 800.0%
Cash From Operating Activities $13.70M
YoY Change 26.85%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities -$318.5M
YoY Change 334.52%
Cash From Investing Activities -$318.5M
YoY Change 334.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 302.9M
YoY Change 233.22%
NET CHANGE
Cash From Operating Activities 13.70M
Cash From Investing Activities -318.5M
Cash From Financing Activities 302.9M
Net Change In Cash -1.900M
YoY Change -106.69%
FREE CASH FLOW
Cash From Operating Activities $13.70M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q2 us-gaap Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
us-gaap:ProductAndServiceOtherMember
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
us-gaap Cash Provided By Used In Financing Activities Discontinued Operations
CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
19517000
CY2020Q2 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
1548000
CY2019Q4 us-gaap Derivative Assets
DerivativeAssets
30000
CY2019Q2 us-gaap Profit Loss
ProfitLoss
8891000
CY2019Q4 us-gaap Management Fee Payable
ManagementFeePayable
701000
CY2020Q2 us-gaap Interest Expense
InterestExpense
12547000
us-gaap Profit Loss
ProfitLoss
-229921000
us-gaap Profit Loss
ProfitLoss
17024000
CY2020Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-484000
CY2019Q2 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-2697000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-7233000
CY2020Q2 us-gaap Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
-33400000
CY2020Q2 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
14696000
CY2020Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1720000
CY2020Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
20000
CY2020Q2 xan Management Fees Related Party
ManagementFeesRelatedParty
1327000
CY2020Q2 xan Equity Compensation Related Party
EquityCompensationRelatedParty
715000
CY2020Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
7000
CY2020Q2 us-gaap Provision For Loan And Lease Losses
ProvisionForLoanAndLeaseLosses
41472000
CY2020Q2 us-gaap Costs And Expenses
CostsAndExpenses
46396000
CY2020Q2 xan Revenues Less Operating Expense
RevenuesLessOperatingExpense
-31680000
CY2020Q2 us-gaap Debt Securities Gain Loss
DebtSecuritiesGainLoss
-982000
CY2020Q2 xan Fair Value And Other Adjustments On Asset Held For Sale
FairValueAndOtherAdjustmentsOnAssetHeldForSale
927000
CY2020Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
189000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31594046
CY2020Q2 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2587000
CY2019Q2 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2587000
xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
5175000
us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-4390000
xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
5175000
CY2019Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9003000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-229921000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
17173000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-149000
us-gaap Profit Loss
ProfitLoss
17024000
xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
5175000
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.14
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31705709
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31438247
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31665956
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31409063
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31705709
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31656180
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31665956
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
38723000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
4733000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
616447000
CY2019Q1 xan Distributions On Common Stock
DistributionsOnCommonStock
-6373000
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
181953000
us-gaap Payments To Acquire Available For Sale Securities Debt
PaymentsToAcquireAvailableForSaleSecuritiesDebt
24610000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
557823000
CY2019Q2 xan Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2587000
CY2019Q2 xan Securities Available For Sale Fair Value Adjustment Net
SecuritiesAvailableForSaleFairValueAdjustmentNet
3326000
CY2019Q2 xan Distributions On Common Stock
DistributionsOnCommonStock
-7172000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
557952000
us-gaap Profit Loss
ProfitLoss
17024000
us-gaap Proceeds From Collection Of Loans Receivable
ProceedsFromCollectionOfLoansReceivable
220024000
us-gaap Proceeds From Sale Of Loans Receivable
ProceedsFromSaleOfLoansReceivable
16592000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
556398000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498000
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-196521000
CY2020Q1 xan Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2588000
CY2020Q1 xan Securities Available For Sale Without An Allowance For Credit Losses Fair Value Adjustment Net
SecuritiesAvailableForSaleWithoutAnAllowanceForCreditLossesFairValueAdjustmentNet
5926000
CY2020Q1 xan Designated Derivatives Fair Value Adjustment
DesignatedDerivativesFairValueAdjustment
-6772000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
342057000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
715000
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-33400000
CY2020Q2 xan Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2587000
CY2020Q2 xan Designated Derivatives Fair Value Adjustment
DesignatedDerivativesFairValueAdjustment
-140000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
306645000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
553819000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
683000
CY2019Q1 us-gaap Profit Loss
ProfitLoss
8133000
CY2019Q1 xan Distributions And Accrual Of Cumulative Preferred Stock Dividends
DistributionsAndAccrualOfCumulativePreferredStockDividends
2588000
CY2019Q1 xan Securities Available For Sale Fair Value Adjustment Net
SecuritiesAvailableForSaleFairValueAdjustmentNet
5865000
CY2019Q1 xan Designated Derivatives Fair Value Adjustment
DesignatedDerivativesFairValueAdjustment
-1716000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-149000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
17173000
xan Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
1213000
xan Share Based Compensation Nonemployee And Directors
ShareBasedCompensationNonemployeeAndDirectors
1095000
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
-186274000
us-gaap Debt Securities Available For Sale Gain Loss
DebtSecuritiesAvailableForSaleGainLoss
4000
xan Fair Value And Other Adjustments On Asset Held For Sale
FairValueAndOtherAdjustmentsOnAssetHeldForSale
4718000
xan Fair Value And Other Adjustments On Asset Held For Sale
FairValueAndOtherAdjustmentsOnAssetHeldForSale
1402000
xan Changes In Operating Assets And Liabilities Operating Activities
ChangesInOperatingAssetsAndLiabilitiesOperatingActivities
8285000
xan Changes In Operating Assets And Liabilities Operating Activities
ChangesInOperatingAssetsAndLiabilitiesOperatingActivities
4462000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
14114000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
17692000
us-gaap Cash Provided By Used In Operating Activities Discontinued Operations
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
-35000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
14114000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17657000
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
199142000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
2588000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
5175000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
8767000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
11913000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-55180000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
358455000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-55180000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
358455000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-23776000
us-gaap Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities
ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities
24003000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
37764000
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
638000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
17290000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-410505000
us-gaap Cash Provided By Used In Investing Activities Discontinued Operations
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
135000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
17290000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-410370000
xan Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
275278000
xan Proceeds From Warehouse Financing Facilities And Repurchase Agreements
ProceedsFromWarehouseFinancingFacilitiesAndRepurchaseAgreements
517142000
xan Proceeds From Issuance Of Securitization Of Notes Payable
ProceedsFromIssuanceOfSecuritizationOfNotesPayable
393280000
xan Proceeds From Issuance Of Securitization Of Notes Payable
ProceedsFromIssuanceOfSecuritizationOfNotesPayable
575811000
xan Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
594636000
xan Repayments Of Warehouse Financing Facilities And Repurchase Agreements
RepaymentsOfWarehouseFinancingFacilitiesAndRepurchaseAgreements
601483000
xan Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
79161000
xan Payments Of Commercial Real Estate Notes Payable
PaymentsOfCommercialRealEstateNotesPayable
109423000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
21182000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
5642000
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
6504000
us-gaap Payments For Proceeds From Derivative Instrument Financing Activities
PaymentsForProceedsFromDerivativeInstrumentFinancingActivities
11762000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-34258000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
94434000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
95474000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70658000
us-gaap Interest Paid Net
InterestPaidNet
25000000
us-gaap Interest Paid Net
InterestPaidNet
36338000
CY2019Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
14062000
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
45100000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
70658000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
61216000
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
19500000
us-gaap Use Of Estimates
UseOfEstimates
<p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and within the period of financial results. Actual results could differ from those estimates. Estimates affecting the accompanying consolidated financial statements include but are not limited to the net realizable and fair values of the Company’s investments and derivatives, the estimated life used on investments to calculate amortization and accretion of premiums and discounts, respectively, provisions for credit losses and the disclosure of contingent liabilities.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:9pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In December 2019, a novel strain of coronavirus (“COVID-19”) was identified. The resulting global proliferation of the virus led the World Health Organization to designate COVID-19 as a pandemic and numerous countries, including the United States, to declare national emergencies. Many countries have responded to the outbreak by instituting quarantines and restrictions on travel, which have resulted in the closure or remote operation of non-essential businesses. Such actions have produced material and previously unforeseeable shocks to global markets, disruptions to global supply chains and adversity to many industries and economies as whole. While certain countries around the world have eased restrictions and financial markets have stabilized to some degree, the pandemic continues to plague the overall economy and cause uncertainty surrounding the ultimate impact on the global economy generally, and the CRE business in particular, that make estimates and assumptions as of June 30, 2020 inherently less certain than they would be absent the current and potential impacts of COVID-19. As a result, actual losses could differ from estimated amounts. The Company believes the estimates and assumptions underlying the consolidated financial statements are reasonable and supportable based on the information available at June 30, 2020. Actual results may ultimately differ from those estimates.</p>
CY2020Q2 xan Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
56300000
CY2019Q4 xan Cash Balance In Excess Of Federal Deposit Insurance Limit Amount
CashBalanceInExcessOfFederalDepositInsuranceLimitAmount
77600000
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
57734000
CY2019Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
47154000
CY2020Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12924000
CY2020Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
32900000
CY2019Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
32900000
CY2020Q2 xan Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
9900000
CY2019Q4 xan Operating Loss Carryforwards Valuation Allowance Tax Expense Impact
OperatingLossCarryforwardsValuationAllowanceTaxExpenseImpact
9900000
CY2020Q1 xan Current Expected Credit Losses Reserve
CurrentExpectedCreditLossesReserve
4500000
CY2020Q1 xan Current Expected Credit Losses Reserve Recorded As Charge To Retained Earnings
CurrentExpectedCreditLossesReserveRecordedAsChargeToRetainedEarnings
3000000.0
CY2020Q1 xan Current Expected Credit Losses Reserve Per Share Recorded As Charge To Retained Earnings
CurrentExpectedCreditLossesReservePerShareRecordedAsChargeToRetainedEarnings
0.10
CY2020Q1 xan Percentage Of Estimated Current Expected Credit Losses Reserve Out Of Aggregate Outstanding Principal Balance Of Commercial Loan Portfolio
PercentageOfEstimatedCurrentExpectedCreditLossesReserveOutOfAggregateOutstandingPrincipalBalanceOfCommercialLoanPortfolio
0.0025
CY2020Q2 xan Percentage Of Credit Losses Reserve Out Of Aggregate Outstanding Principal Balance Of Commercial Loan Portfolio
PercentageOfCreditLossesReserveOutOfAggregateOutstandingPrincipalBalanceOfCommercialLoanPortfolio
0.0344
CY2019Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
520714000
CY2019Q4 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
466900000
CY2020Q2 us-gaap Pledged Financial Instruments Not Separately Reported Securities Pledged
PledgedFinancialInstrumentsNotSeparatelyReportedSecuritiesPledged
0
us-gaap Financing Receivable Modifications Number Of Contracts2
FinancingReceivableModificationsNumberOfContracts2
1
CY2020Q2 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
19916000
CY2020Q2 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1745964000
CY2020Q2 xan Financing Receivable Recorded Investment Past Due And Current
FinancingReceivableRecordedInvestmentPastDueAndCurrent
1765880000
CY2020Q2 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
11516000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Past Due
FinancingReceivableRecordedInvestmentPastDue
11503000
CY2019Q4 us-gaap Financing Receivable Recorded Investment Current
FinancingReceivableRecordedInvestmentCurrent
1779942000
CY2019Q4 xan Financing Receivable Recorded Investment Past Due And Current
FinancingReceivableRecordedInvestmentPastDueAndCurrent
1791445000
CY2019Q4 us-gaap Financing Receivable Recorded Investment90 Days Past Due And Still Accruing
FinancingReceivableRecordedInvestment90DaysPastDueAndStillAccruing
11503000
CY2019Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
514894000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
7591000
CY2019Q4 us-gaap Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1771000
xan Debt Securities Available For Sale Loss
DebtSecuritiesAvailableForSaleLoss
186300000
us-gaap Available For Sale Debt Securities Gross Unrealized Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedLoss
6000000.0
CY2020Q2 xan Available For Sale Debt Securities Gross Unrealized Additional Loss
AvailableForSaleDebtSecuritiesGrossUnrealizedAdditionalLoss
917000
CY2020Q2 xan Debt Securities Available For Sale Number Of Securities Sold Or Redeemed
DebtSecuritiesAvailableForSaleNumberOfSecuritiesSoldOrRedeemed
2
CY2019Q2 us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
us-gaap Other Than Temporary Impairment Loss Debt Securities Available For Sale Recognized In Earnings
OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSaleRecognizedInEarnings
0
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1555462000
CY2020Q2 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
19372000
CY2020Q2 us-gaap Notes Payable
NotesPayable
1536090000
CY2020Q2 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0210
xan Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P11Y10M24D
CY2020Q2 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
1727391000
CY2019Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1891796000
CY2019Q4 us-gaap Notes Payable
NotesPayable
1872577000
CY2019Q4 us-gaap Longterm Debt Weighted Average Interest Rate
LongtermDebtWeightedAverageInterestRate
0.0345
CY2019 xan Debt Instrument Maturity Date Free Form
DebtInstrumentMaturityDateFreeForm
P7Y4M24D
CY2019Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
2170546000
CY2019Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
919805000
CY2019Q4 us-gaap Securities Loaned Fair Value Of Collateral
SecuritiesLoanedFairValueOfCollateral
1189619000
CY2020Q2 us-gaap Long Term Debt
LongTermDebt
1555462000
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
111079000
CY2020Q2 xan Longterm Debt Maturing In Year Two
LongtermDebtMaturingInYearTwo
122207000
CY2020Q2 xan Longterm Debt Maturing In Year Three
LongtermDebtMaturingInYearThree
143750000
CY2020Q2 xan Longterm Debt Maturing In Year Four
LongtermDebtMaturingInYearFour
0
CY2020Q2 xan Longterm Debt Maturing In Year Five And After
LongtermDebtMaturingInYearFiveAndAfter
1178426000
CY2020Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
231764000
CY2020Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2019Q2 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
0
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
715000
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
412000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1213000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1095000
CY2020Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-33400000
CY2019Q2 us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
9003000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
-229921000
us-gaap Income Loss From Continuing Operations
IncomeLossFromContinuingOperations
17173000
CY2020Q2 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2587000
CY2019Q2 xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
2587000
xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
5175000
xan Comprehensive Income Loss Net Of Tax Attributable To Preferred Stockholders
ComprehensiveIncomeLossNetOfTaxAttributableToPreferredStockholders
5175000
CY2020Q2 xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
-35987000
CY2019Q2 xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
6416000
xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
-235096000
xan Net Income Loss From Continuing Operations Allocable To Common Shares
NetIncomeLossFromContinuingOperationsAllocableToCommonShares
11998000
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
CY2019Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-112000
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Attributable To Reporting Entity
IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity
-149000
CY2020Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-35987000
CY2019Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
6304000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-235096000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
11849000
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31705709
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31438247
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31665956
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
31409063
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
217933
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
184983
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31705709
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31656180
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31665956
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
31594046
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-1.14
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.20
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
-7.42
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.14
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.20
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-7.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.38
xan Reit Required Taxable Income Distribution Percentage
REITRequiredTaxableIncomeDistributionPercentage
0.90
xan Reit Taxable Income Distribution For Exempt Federal Income Taxes Percentage
REITTaxableIncomeDistributionForExemptFederalIncomeTaxesPercentage
1
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0
CY2019Q4 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
4558000
us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.38
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2019Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Basic Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
0
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.14
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.20
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-7.42
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.38
CY2020Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-1.14
CY2019Q2 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.20
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
-7.42
us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.38
CY2020Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2019Q2 us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
us-gaap Income Loss From Discontinued Operations Net Of Tax Per Diluted Share
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
30000
CY2019Q4 us-gaap Derivative Asset Fair Value Gross Liability
DerivativeAssetFairValueGrossLiability
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Asset Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeAssetAmountNotOffsetAgainstCollateral
30000
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Securities
DerivativeCollateralObligationToReturnSecurities
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
4558000
CY2019Q4 us-gaap Derivative Collateral Obligation To Return Cash
DerivativeCollateralObligationToReturnCash
0
CY2019Q4 us-gaap Derivative Asset Fair Value Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeAssetFairValueOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
30000
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
0
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
77000
CY2020Q2 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral
77000
CY2020Q2 us-gaap Derivative Collateral Right To Reclaim Securities
DerivativeCollateralRightToReclaimSecurities
0
CY2020Q2 us-gaap Derivative Collateral Right To Reclaim Cash
DerivativeCollateralRightToReclaimCash
77000
CY2020Q2 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
231764000
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2020Q2 xan Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
231764000
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
231764000
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
0
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2020Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
231841000
CY2020Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0
CY2020Q2 xan Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Not Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountNotOffsetAgainstCollateral
231841000
CY2020Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
231764000
CY2020Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
77000
CY2020Q2 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
4558000
CY2019Q4 us-gaap Derivative Liability Fair Value Gross Asset
DerivativeLiabilityFairValueGrossAsset
0
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Liability Amount Offset Against Collateral
DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral
0
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Gross
SecuritiesSoldUnderAgreementsToRepurchaseGross
919805000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Asset
SecuritiesSoldUnderAgreementsToRepurchaseAsset
0
CY2019Q4 xan Securities Sold Under Agreements To Repurchase Amount Not Offset Against Collateral
SecuritiesSoldUnderAgreementsToRepurchaseAmountNotOffsetAgainstCollateral
919805000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Securities
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimSecurities
915041000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Collateral Right To Reclaim Cash
SecuritiesSoldUnderAgreementsToRepurchaseCollateralRightToReclaimCash
4764000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
SecuritiesSoldUnderAgreementsToRepurchaseOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Gross
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedGross
924363000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Asset
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAsset
0
CY2019Q4 xan Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Amount Not Offset Against Collateral
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedAmountNotOffsetAgainstCollateral
924363000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Securities
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimSecurities
915041000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Collateral Right To Reclaim Cash
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedCollateralRightToReclaimCash
9322000
CY2019Q4 us-gaap Derivative Liability Securities Sold Under Agreements To Resell Securities Loaned Offset Against Collateral Net Of Not Subject To Master Netting Arrangement Policy Election
DerivativeLiabilitySecuritiesSoldUnderAgreementsToResellSecuritiesLoanedOffsetAgainstCollateralNetOfNotSubjectToMasterNettingArrangementPolicyElection
0
CY2020Q2 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
348100000
CY2019Q4 us-gaap Securities Sold Under Agreements To Repurchase Fair Value Of Collateral
SecuritiesSoldUnderAgreementsToRepurchaseFairValueOfCollateral
1200000000
CY2020Q2 us-gaap Litigation Reserve
LitigationReserve
0
CY2019Q4 us-gaap Litigation Reserve
LitigationReserve
0

Files In Submission

Name View Source Status
0001564590-20-038891-index-headers.html Edgar Link pending
0001564590-20-038891-index.html Edgar Link pending
0001564590-20-038891.txt Edgar Link pending
0001564590-20-038891-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
glw4o3oaxjn5000001.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R100.htm Edgar Link pending
R101.htm Edgar Link pending
R102.htm Edgar Link pending
R103.htm Edgar Link pending
R104.htm Edgar Link pending
R105.htm Edgar Link pending
R106.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
R98.htm Edgar Link pending
R99.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
xan-10q_20200630.htm Edgar Link pending
xan-10q_20200630_htm.xml Edgar Link completed
xan-20200630.xsd Edgar Link pending
xan-20200630_cal.xml Edgar Link unprocessable
xan-20200630_def.xml Edgar Link unprocessable
xan-20200630_lab.xml Edgar Link unprocessable
xan-20200630_pre.xml Edgar Link unprocessable
xan-ex104_264.htm Edgar Link pending
xan-ex311_9.htm Edgar Link pending
xan-ex312_7.htm Edgar Link pending
xan-ex321_10.htm Edgar Link pending
xan-ex322_11.htm Edgar Link pending